A detailed history of Pnc Financial Services Group, Inc. transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 65,000 shares of LVTX stock, worth $67,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,000
Previous 65,000 -0.0%
Holding current value
$67,600
Previous $117,000 8.55%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$1.4 - $2.6 $21,000 - $39,000
15,000 Added 30.0%
65,000 $131,000
Q4 2022

Feb 10, 2023

BUY
$3.37 - $7.31 $168,500 - $365,500
50,000 New
50,000 $175,000

Others Institutions Holding LVTX

About LAVA Therapeutics NV


  • Ticker LVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,797,700
  • Market Cap $26.8M
  • Description
  • LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...
More about LVTX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.